AIM:To investigate the effects of the Chinese herbal decoction,Yi-Qi-Zeng-Min-Tang(YQZMT),on insulin resistance in type 2 diabetic rats.METHODS:Sprague-Dawley rats were divided into two dietary regiments by feeding ei...AIM:To investigate the effects of the Chinese herbal decoction,Yi-Qi-Zeng-Min-Tang(YQZMT),on insulin resistance in type 2 diabetic rats.METHODS:Sprague-Dawley rats were divided into two dietary regiments by feeding either normal pellet diet(NPD) or high fat diet(HFD).Four weeks later,the HFD-fed rats were injected intraperitoneally with lowdose streptozotocin(STZ).Rats with non-fasting blood glucose level ≥ 16.67 mmol/L were considered type 2 diabetic and further divided into five subgroups:the type 2 diabetes model group,low-dose,medium-doseand high-dose YQZMT groups,and rosiglitazone group.Age-matched NPD-fed rats served as controls.YQZMT or rosiglitazone were administered for 8 wk.Intraperitoneal glucose and insulin tolerance tests were performed before and after the treatment to measure the glucose tolerance and insulin sensitivity.Serum levels of biochemical parameters,adipocytokines,such as tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),as well as free fatty acids(FFAs),were also analyzed.RESULTS:There was significant elevation of insulin resistance and serum levels of fasting glucose(12.82 ± 1.08 mmol/L vs 3.60 ± 0.31 mmol/L,P < 0.01),insulin(7197.36 ± 253.89 pg/mL vs 4820.49 ± 326.89 pg/mL,P < 0.01),total cholesterol(TC)(8.40 ± 0.49 mmol/L vs 2.14 ± 0.06 mmol/L,P < 0.01),triglyceride(2.24 ± 0.12 mmol/L vs 0.78 ± 0.05 mmol/L,P < 0.01),low-density lipoprotein cholesterol(LDL-c)(7.84 ± 0.51 mmol/L vs 0.72 ± 0.04 mmol/L,P < 0.01) and decrease in high-density lipoprotein cholesterol(HDL-c)(0.57 ± 0.03 mmol/L vs 1.27 ± 0.03 mmol/L,P < 0.01) in the low-dose STZ and high-fat diet induced type 2 diabetic group when compared with the control group.Administration of YQZMT induced dose-and timedependent changes in insulin resistance,glucose and lipid profile,and reduced levels of FFA,TNF-α and IL-6 in the type 2 diabetic rats.After the treatment,compared with the diabetic group,the insulin resistance was ameliorated in the high-dose YQZMT(2.82 g/100 g per day) group,with a significant reduction in serum glucose(12.16 ± 1.00 mmol/L vs 17.65 ± 2.22 mmol/L,P < 0.01),homeostasis model assessment of basal insulin resistance(22.68 ± 2.37 vs 38.79 ± 9.02,P < 0.05),triglyceride(0.87 ± 0.15 mmol/L vs 1.99 ± 0.26 mmol/L,P < 0.01),TC(3.31 ± 0.52 mmol/L vs 6.50 ± 1.04 mmol/L,P < 0.01) and LDL-c(2.47 ± 0.50 mmol/L vs 6.00 ± 1.07 mmol/L,P < 0.01),and a signif icant increase in HDL-c(0.84 ± 0.08 mmol/L vs 0.50 ± 0.03 mmol/L,P < 0.01).But the body weight was not changed signif icantly.CONCLUSION:YQZMT,which ameliorates insulin resistance and does not cause increase in body weight,may be a suitable therapeutic adjunct for the treatment of type 2 diabetes.展开更多
The present study examined the influence of leucine metabolite β-hydroxy-β-methylbutyrate （HMB） on the nonspecific cellular and humoral defence mechanisms and protection against Yersinia ruckeri and Aeromonas salm...The present study examined the influence of leucine metabolite β-hydroxy-β-methylbutyrate （HMB） on the nonspecific cellular and humoral defence mechanisms and protection against Yersinia ruckeri and Aeromonas salmonicida in juvenile pikeperch （Sander lucioperca）. The fish was fed with a commercial trout pellets, containing either 0 （control group） or 50 mg HMB kg^-1 body weight day^-1 （HMB fed group）. After four weeks feeding, 20 pikeperch from each group were anaesthetised and blood and pronephros samples were taken. The levels of the following immunological parameters were measured： respiratory burst activity of phagocytes, potential killing activity of phagocytes, lymphocytes proliferation stimulated by concanavaline A or lipopolisaccharide, lysozyme activity in serum, ceruloplasmin activity in serum, total protein in serum and total immunoglobulin （Ig） level in serum. A disease challenge test using Yersinia ruckeri or Aeromonas salmonicida was conducted after 4 weeks of feeding. The levels of all immunological parameters excluding ceruloplasmin activity and total protein in serum were statistically significantly higher （P 〈 0.05） in the HMB treated group compared to the control group. Feeding with HMB has led to a significant decrease in the mortality after the challenge trial with Y. ruckeri （30% lower mortality than in the control group） and with theA. salmonicida （40% lower mortality than in the control group）. The current study strongly suggests that feeding pikeperch with HMB in dose 50 mg kg^-1 body weight day^-1 may improve the innate immunity and decrease the mortality rates after experimental infection with pathogenic bacteria Y. ruckeri and A. salmonicida.展开更多
基金Supported by The Fok Ying-Tong Education Foundation, China, No. 114036Leading Academic Discipline Project of Shanghai Municipal Education Commission, No. J50307State Administration of Traditional Chinese Medicine
文摘AIM:To investigate the effects of the Chinese herbal decoction,Yi-Qi-Zeng-Min-Tang(YQZMT),on insulin resistance in type 2 diabetic rats.METHODS:Sprague-Dawley rats were divided into two dietary regiments by feeding either normal pellet diet(NPD) or high fat diet(HFD).Four weeks later,the HFD-fed rats were injected intraperitoneally with lowdose streptozotocin(STZ).Rats with non-fasting blood glucose level ≥ 16.67 mmol/L were considered type 2 diabetic and further divided into five subgroups:the type 2 diabetes model group,low-dose,medium-doseand high-dose YQZMT groups,and rosiglitazone group.Age-matched NPD-fed rats served as controls.YQZMT or rosiglitazone were administered for 8 wk.Intraperitoneal glucose and insulin tolerance tests were performed before and after the treatment to measure the glucose tolerance and insulin sensitivity.Serum levels of biochemical parameters,adipocytokines,such as tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),as well as free fatty acids(FFAs),were also analyzed.RESULTS:There was significant elevation of insulin resistance and serum levels of fasting glucose(12.82 ± 1.08 mmol/L vs 3.60 ± 0.31 mmol/L,P < 0.01),insulin(7197.36 ± 253.89 pg/mL vs 4820.49 ± 326.89 pg/mL,P < 0.01),total cholesterol(TC)(8.40 ± 0.49 mmol/L vs 2.14 ± 0.06 mmol/L,P < 0.01),triglyceride(2.24 ± 0.12 mmol/L vs 0.78 ± 0.05 mmol/L,P < 0.01),low-density lipoprotein cholesterol(LDL-c)(7.84 ± 0.51 mmol/L vs 0.72 ± 0.04 mmol/L,P < 0.01) and decrease in high-density lipoprotein cholesterol(HDL-c)(0.57 ± 0.03 mmol/L vs 1.27 ± 0.03 mmol/L,P < 0.01) in the low-dose STZ and high-fat diet induced type 2 diabetic group when compared with the control group.Administration of YQZMT induced dose-and timedependent changes in insulin resistance,glucose and lipid profile,and reduced levels of FFA,TNF-α and IL-6 in the type 2 diabetic rats.After the treatment,compared with the diabetic group,the insulin resistance was ameliorated in the high-dose YQZMT(2.82 g/100 g per day) group,with a significant reduction in serum glucose(12.16 ± 1.00 mmol/L vs 17.65 ± 2.22 mmol/L,P < 0.01),homeostasis model assessment of basal insulin resistance(22.68 ± 2.37 vs 38.79 ± 9.02,P < 0.05),triglyceride(0.87 ± 0.15 mmol/L vs 1.99 ± 0.26 mmol/L,P < 0.01),TC(3.31 ± 0.52 mmol/L vs 6.50 ± 1.04 mmol/L,P < 0.01) and LDL-c(2.47 ± 0.50 mmol/L vs 6.00 ± 1.07 mmol/L,P < 0.01),and a signif icant increase in HDL-c(0.84 ± 0.08 mmol/L vs 0.50 ± 0.03 mmol/L,P < 0.01).But the body weight was not changed signif icantly.CONCLUSION:YQZMT,which ameliorates insulin resistance and does not cause increase in body weight,may be a suitable therapeutic adjunct for the treatment of type 2 diabetes.
文摘The present study examined the influence of leucine metabolite β-hydroxy-β-methylbutyrate （HMB） on the nonspecific cellular and humoral defence mechanisms and protection against Yersinia ruckeri and Aeromonas salmonicida in juvenile pikeperch （Sander lucioperca）. The fish was fed with a commercial trout pellets, containing either 0 （control group） or 50 mg HMB kg^-1 body weight day^-1 （HMB fed group）. After four weeks feeding, 20 pikeperch from each group were anaesthetised and blood and pronephros samples were taken. The levels of the following immunological parameters were measured： respiratory burst activity of phagocytes, potential killing activity of phagocytes, lymphocytes proliferation stimulated by concanavaline A or lipopolisaccharide, lysozyme activity in serum, ceruloplasmin activity in serum, total protein in serum and total immunoglobulin （Ig） level in serum. A disease challenge test using Yersinia ruckeri or Aeromonas salmonicida was conducted after 4 weeks of feeding. The levels of all immunological parameters excluding ceruloplasmin activity and total protein in serum were statistically significantly higher （P 〈 0.05） in the HMB treated group compared to the control group. Feeding with HMB has led to a significant decrease in the mortality after the challenge trial with Y. ruckeri （30% lower mortality than in the control group） and with theA. salmonicida （40% lower mortality than in the control group）. The current study strongly suggests that feeding pikeperch with HMB in dose 50 mg kg^-1 body weight day^-1 may improve the innate immunity and decrease the mortality rates after experimental infection with pathogenic bacteria Y. ruckeri and A. salmonicida.
